ライフサイエンスコーパス: AChE

1 AChE catalyses the cleavage of acetylthiocholine chlorid

2 AChE in red blood cells is a surrogate for AChE in the n

3 AChE inhibition based amperometric OP biosensors exhibit

4 AChE is clustered by the collagen Q in the synaptic clef

5 AChE staining at the borders of adjacent fields are cons

6 AChE was solubilized from frozen RBC by addition of 1% T

7 positions 4, 6, or 7 conferred both acetyl (AChE) and butyryl (BuChE) cholinesterase inhibitory acti

8 Acetylcholinesterase (AChE) biosensor was developed through silica sol-gel (Si

9 Acetylcholinesterase (AChE) converts ACh to choline, which in turn is oxidized

10 Acetylcholinesterase (AChE) inhibitors are commonly used pesticides that can e

11 Acetylcholinesterase (AChE) is crucial for degrading acetylcholine at choliner

12 OF-Basolite Z1200) and Acetylcholinesterase (AChE) enzyme served as an excellent electro-analytical t

13 n-converting (ACE) and acetylcholinesterase (AChE) enzymes.

14 argeting clearance and acetylcholinesterase (AChE) inhibition in AD therapy.

15 l, anti-parasitic, and acetylcholinesterase (AChE) inhibitory activity, were detected in apples.

16 tion of human BChE and acetylcholinesterase (AChE) with metaproterenol, isoproterenol, and newly synt

17 ously established AOP, acetylcholinesterase (AChE) inhibition.

18 and their potential as acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitors was a

19 ibitory effect on both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE).

20 the kinetics of brain Acetylcholinesterase (AChE) during adaptation to sublethal temperatures by acc

21 nitin, a novel dimeric acetylcholinesterase (AChE) inhibitor derived from tacrine, prevented Abeta ol

22 's disease (AD), i.e., acetylcholinesterase (AChE) and monoamine oxidase B (MAO B), a series of multi

23 sitive electrochemical acetylcholinesterase (AChE) biosensor was successfully developed on polyanilin

24 genetically-engineered acetylcholinesterase (AChE) immobilized in a azide-unit water-pendant polyviny

25 ons between the enzyme acetylcholinesterase (AChE) and two compound classes consisting of N-[2-(dieth

26 an body, by the enzyme acetylcholinesterase (AChE) is fundamental for the termination of ACh impulse

27 target was the enzyme acetylcholinesterase (AChE), and the AChE-ICERs produced were used in a liquid

28 ive site of the enzyme acetylcholinesterase (AChE).

29 e (ACE) and the enzyme acetylcholinesterase (AChE).

30 immobilizing enzymes, acetylcholinesterase (AChE) and choline oxidase (ChO), on the surface of iron

31 inst human erythrocyte acetylcholinesterase (AChE), equine serum butyrylcholinesterase (BChE), and a

32 ds displayed excellent acetylcholinesterase (AChE) inhibitory potencies and interesting capabilities

33 c compounds, exhibited acetylcholinesterase (AChE) inhibitory activity and also displayed effective i

34 = 0.312 and 0.301) for acetylcholinesterase (AChE) or butylcholinoesterase (BuChE), respectively.

35 ins were performed for acetylcholinesterase (AChE), nicotinamide adenine dinucleotide phosphate-diaph

36 potencies toward human acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) that retain or im

37 Human acetylcholinesterase (AChE) is a significant target for therapeutic drugs.

38 ies, and inhibit human acetylcholinesterase (AChE).

39 OPs inactivate acetylcholinesterase (AChE) by covalently modifying its catalytic serine.

40 tes for OP-inactivated acetylcholinesterase (AChE) were lower compared to 2-PAM but greater compared

41 rgic factors including acetylcholinesterase (AChE), choline acetyltransferase (ChAT), choline transpo

42 ecticides that inhibit acetylcholinesterase (AChE) enzyme activity in the salmon nervous system, ther

43 sidues of OP-inhibited acetylcholinesterase (AChE) in orientations that are nonproductive for AChE re

44 arfare agent inhibited acetylcholinesterase (AChE) with promising in vitro potential was developed by

45 d methylcarbamate (MC) acetylcholinesterase (AChE) inhibitors.

46 tate receptor (NMDAR), acetylcholinesterase (AChE), and monoamine oxidase B (MAO-B).

47 uding determination of acetylcholinesterase (AChE) activity, genotoxicity and oxidative stress using

48 stinct localization of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) at the NMJ to bri

49 ated via inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), and tyrosinase (

50 valently, a mixture of acetylcholinesterase (AChE) and choline oxidase (ChO) onto nanocomposite of ch

51 sensitive detection of acetylcholinesterase (AChE) and its inhibitor using a cationic surfactant-deco

52 ugh dual inhibition of acetylcholinesterase (AChE) and microRNA-15b biogenesis.

53 ated the expression of acetylcholinesterase (AChE) and the density of myelinated axons throughout pos

54 catalytic subunits of acetylcholinesterase (AChE) are anchored in the basal lamina of the neuromuscu

55 crystal structures of acetylcholinesterase (AChE) in complex with galantamine derivatives.

56 ng the distribution of acetylcholinesterase (AChE) in the hippocampal formation of terrestrial mammal

57 versible inhibition of acetylcholinesterase (AChE) in the nervous system.

58 ial period and that of acetylcholinesterase (AChE) increased during a later time period.

59 ns through blockade of acetylcholinesterase (AChE) whereas antidepressant-like effects can be produce

60 ced by the addition of acetylcholinesterase (AChE), and thus appears to involve ACh spillover.

61 d in the regulation of acetylcholinesterase (AChE), which is a key protein of the cholinergic system

62 ve to perturbations of acetylcholinesterase (AChE), while slow non-alpha7 receptor-mediated EPSCs are

63 sprouting response of acetylcholinesterase (AChE)-positive fibers, a phenotype reminiscent of human

64 nd peripheral sites of acetylcholinesterase (AChE).

65 igand binding sites on acetylcholinesterase (AChE) comprise an active center, at the base of a deep a

66 ther biological roles, acetylcholinesterase (AChE, EC 3.1.1.7), encoded by two ace in most insects, c

67 is, a highly sensitive acetylcholinesterase (AChE) cyclic voltammetric biosensor based on zinc oxide

68 dropyran isomer showed acetylcholinesterase (AChE) inhibitory activity.

69 s also a submicromolar acetylcholinesterase (AChE) inhibitor and therefore, could contribute, through

70 y of newly synthesized acetylcholinesterase (AChE) molecules do not assemble into catalytically activ

71 w that miR-608 targets acetylcholinesterase (AChE) and demonstrate weakened miR-608 interaction with

72 RNA) homologous to the acetylcholinesterase (AChE) and ecdysone receptor (EcR) genes of B. tabaci, re

73 alysis (EDA) using the acetylcholinesterase (AChE) bioassay and metabolomics.

74 the performance of the acetylcholinesterase (AChE) enzyme.

75 By utilizing the acetylcholinesterase (AChE) mediated hydrolysis of acetylthiocholine to thioch

76 and a high throughput acetylcholinesterase (AChE) assay was developed.

77 tory properties toward acetylcholinesterase (AChE) in relation to tacrine.

78 the conjugates toward acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and structurally clo

79 ry described here uses acetylcholinesterase (AChE) and produces an unambiguous color change when the

80 binding mechanism with acetylcholinesterase (AChE) as its more potent counterparts such as sarin and

81 lves reacting ACh with acetylcholinesterase (AChE) to form choline that is in turn oxidized by cholin

82 nd surface coated with acetylcholinesterase (AChE) were attached to gold screen printed electrodes to

83 in and conjugated with acetylcholinesterase (AChE), an enzyme specific for acetylcholine, resulting i

84 reviously that insect acetylcholinesterases (AChEs) could be selectively and irreversibly inhibited b

85 the highly potent catalytic enzyme for ACh, AChE, to facilitate measurement of ACh.

86 A gamma-secretase inhibitor did not affect AChE transcript levels or enzyme activity in SN56 (APP69

87 ped a computational strategy and designed an AChE variant bearing 51 mutations that improved core pac

88 tively, using C-dots@RGO (0.4 mg.mL(-1)) and AChE and ChOx at the activities of 0.5 and 0.1 unit.mL(-

89 tive MAO-B (high selectivity over MAO-A) and AChE inhibitor in the series with IC(50) values of 4.27

90 ermined at various concentrations of ACh and AChE.

91 vivo interactions of the nAChR agonists and AChE inhibitors.

92 Targeted chemical analysis and AChE bioassay were performed on the cartridge extracts.

93 mpounds were evaluated for MAO-A, MAO-B, and AChE inhibitory activities as potential drug candidates

94 " Applying immunohistochemistry for ChAT and AChE on sections of the chicken retina, we here have rev

95 nthesis established SAR delineating ChK1 and AChE activities and allowing identification of new leads

96 rofiles of the binding between compounds and AChE revealed class-dependent differences of the entropy

97 oes had the highest ACE (0.50-0.44mg/mL) and AChE (7.93-5.83mg/mL) inhibitory activity.

98 is Water Maze Test, Radial Arm Maze Test and AChE activity in scopolamine induced amnetic rats.

99 ntly correlated with BSA-MGO, anti-ACE, anti-AChE and PCLACW parameters.

100 enhanced the anti-ACE (14.09 mg/mL) and anti-AChE (16.95 mg/mL) potentials of the tested extract rela

101 The anti-BuChE effect was higher than anti-AChE, while products with apricot, orange, grape and par

102 P) pesticides, warfare agents and drugs, are AChE reversible or irreversible inhibitors, thus their r

103 As AChE is deeply conserved, widely expressed outside of th

104 and in turn increases total cell-associated AChE activity and active tetramer secretion.

105 showed good inhibitory activities at MAO-B, AChE, and BChE but low selectivity.

106 Pearson's correlations between AChE and BuChE inhibition and phenolic acid content were

107 When both AChE and BChE were inhibited, the spillover increased an

108 small transmembrane protein anchor of brain AChE.

109 but now also correlating with in vivo brain AChE inhibition, indicating that ACh is the ultimate OP-

110 e (Ch) which in turn interacts with AuQC@BSA-AChE and quenches its fluorescence, enabling sensing.

111 Further, the sensor, AuQC@BSA-AChE can be easily coated on paper and an efficient and

112 This suggests that AuQC@BSA-AChE has an excellent potential to be used for diagnosis

113 The fluorescent intensity of AuQC@BSA-AChE is sensitive towards acetylcholine in range of 10nM

114 fic for acetylcholine, resulting in AuQC@BSA-AChE.

115 ree coupled enzymatic reactions catalyzed by AChE, choline oxidase and horseradish peroxidase, leadin

116 of how retinal networks became dominated by AChE or by ChAT reactivities.

117 ing the beta-amyloid aggregation promoted by AChE.

118 eased tolerance to the insecticide carbaryl (AChE-inhibitor) can induce increased tolerance to other

119 purification method to enrich red blood cell AChE (RBC AChE) as a biomarker of exposure.

120 , indicating the future IPL, pairs of ChAT+ /AChE- /Brn3a- cells appeared between E7/8.

121 inhibition of enzyme, acetyl cholinesterase (AChE), butyryl cholinesterase (BChE), tyrosinase and alk

122 AOs) and acetyl- and butyryl-cholinesterase (AChE and BChE) inhibitors.

123 In conclusion, AChE is regulated in two neuronal cell lines by APP in a

124 ited nAChR in vivo without the corresponding AChE inhibition, possibly via a reactive ketene metaboli

125 Despite precursor binding to crystalline AChE, coupling of rapid electric field fluctuations in t

126 Denatured AChE was eluted with 1% trifluoroacetic acid.

127 the lateral regions of the EC display denser AChE staining than that of the medial banks.

128 ionic site (PAS) of Electrophorus electricus AChE (EeAChE) and competitively displace propidium iodid

129 Mutations in COLQ cause endplate AChE deficiency.

130 xon 16 identified in a patient with endplate AChE deficiency causes exclusive skipping of exon 16.

131 The peptides act to enhance AChE folding thereby rescuing them from reticulum degrad

132 The enzyme, AChE hydrolyzes acetylcholine (ACh) to choline (Ch) whic

133 Erythrocyte AChE activity was measured using the EQM Test-mate syste

134 potent inhibitor of acetylcholine esterase (AChE) and unsuitable for development.

135 ng the Ellman assay to measure ACh esterase (AChE) activity that breaks down ACh, the second experime

136 llow the activity of acetylcholine esterase, AChE, and to probe its inhibition.

137 that muscle cells, or cell lines expressing AChE catalytic subunits, incubated with synthetic prolin

138 On either side of a faint AChE+ band, indicating the future IPL, pairs of ChAT+ /A

139 a cumulative 0.05 of the predicted EC50 for AChE inhibition, as determined from single chemical conc

140 tivity (IC50 value of 0.30 +/- 0.01 muM) for AChE and (1.84 +/- 0.03 muM) for BuChE.

141 ) in orientations that are nonproductive for AChE reactivation, and the structural diversity of OPs i

142 scontinuous layer 2 modules are positive for AChE, NADPH-d, GAD, and CO throughout the rostrocaudal L

143 bservations point to a prime requirement for AChE to interconvert dynamically between sequential conf

144 AChE in red blood cells is a surrogate for AChE in the nervous system.

145 In animals lacking functional AChE in the CNS (PRiMA(-/-) mice) the EPSCs resembled th

146 dotes that promote the release of functional AChE by an unknown reactivation mechanism.

147 de chain motions in the gorge that may guide AChE toward a transient state favoring syn-triazole form

148 t human acetyl- and butyrylcholinesterase (h-AChE and h-BuChE), being more potent than the parent inh

149 The tacrine-silibinin codrug shows high AChE and BChE inhibition, neuroprotective effects, lacks

150 d molecular genetic decreases in hippocampal AChE activity increased anxiety- and depression-like beh

151 that shRNA-mediated knockdown of hippocampal AChE represents a model for anxiety- and depression-like

152 Overall, however, AChE-staining suggested that cholinergic innervation, ne

153 Thirty chemicals found to inhibit human AChE in the ToxCast assay were examined with respect to

154 ve and venomous agent X (VX)-inhibited human AChE, here we created seven uncharged acetamido bis-oxim

155 -, tabun- and ethyl paraoxon-inhibited human AChE.

156 nd to be the most potent inhibitors of human AChE (hAChE), demonstrating IC50 values of 0.0154 and 0.

157 atalytic active site and to the PAS of human AChE and BChE.

158 as mixed-type reversible inhibitors of human AChE and BuChE with high active site contact.

159 These crystals of human AChE provide a more accurate platform for further drug d

160 nd scarcity of structural knowledge on human AChE (hAChE).

161 ed in vitro reactivation of diverse OP-human AChE conjugates.

162 3,604-458,597 M(-1)sec(-1) but spared human AChE.

163 ifferential HTS analysis including the human AChE, several structurally diverse, potent, and selectiv

164 on irreversibly inhibited mosquito and human AChEs with k(inact)/K(I) values of 1,915 and 1,507 M(-1)

165 method was successfully applied to identify AChE inhibitors in a wastewater treatment plant (WWTP) e

166 m hydrolysis of acetylcholine by immobilized AChE.

167 ate long-lasting stress-inducible changes in AChE's promoter choices, identify the chromatin changes

168 A 1-U/mL decrease in AChE activity was associated with a 2.86-mmHg decrease i

169 P resulted in a significant up-regulation in AChE mRNA levels.

170 le or greater reactivation of OP-inactivated AChE and OP-inactivated BChE.

171 Administration of fluoxetine also increased AChE activity throughout the brain, with the greatest ch

172 The remaining 22 compounds may inhibit AChE in vivo either directly or as a result of metabolic

173 Inhibited AChE cannot hydrolyze the neurotransmitter acetylcholine

174 E into reactivators of nerve agent-inhibited AChE.

175 We found that MB-gCs effectively inhibited AChE and BChE with IC(50) values in the range 1.73-10.5

176 y treatment of rHDL/Do efficiently inhibited AChE activity, ameliorated neurologic variation, promote

177 ncy for reactivation of Sarin (GB)-inhibited AChE and BChE.

178 inhibitors, as they progressively inhibited AChE 960 to 80 times more slowly than BChE(UU).

179 presin can be used to enrich soman-inhibited AChE solubilized from 8 mL of frozen human erythrocytes,

180 nt-of-need detection of chemicals inhibiting AChE.

181 Absent such inhibition, AChE limits the presence of ambient ACh and thus renders

182 d to pharmacomodulate RS67333 to enhance its AChE inhibitory activity to take advantage of this pleio

183 Pulse-chase studies of isotopically labeled AChE molecules show that the enzyme is rescued from intr

184 n vivo completely abolished the long-lasting AChE-related and behavioral stress effects.

185 These features launched AChE as a reaction vessel for in situ click-chemistry sy

186 on, subband "a" presented more ChAT but less AChE; in subband "d" this pattern was reversed.

187 nd demonstrate the early onset of adult-like AChE expression in primary auditory cortex in O. garnett

188 Type-I cells had increased ChAT and lost AChE; type-II cells presented less ChAT, but some AChE o

189 This method can be used to screen for mixed AChE inhibitors, agents that have shown high efficacy ag

190 confirm that reliable fluorescent monitoring AChE-catalyzed hydrolysis of ACh is possible through the

191 eversibly inhibited African malaria mosquito AChE with bimolecular inhibition rate constants (k(inact

192 ect neighbors of SACs tended to express much AChE.

193 t antidote HI-6 in complex with Mus musculus AChE covalently inhibited by the nerve agent sarin.

194 nteracted enzyme-armored MWCNT-OPH and MWCNT-AChE along with a set of cushioning bilayers consisting

195 , suggesting an adaptation to the absence of AChE.

196 idotes need to include much better access of AChE reactivators to the CNS and optimized orientation o

197 n of BChE counteracts the positive action of AChE inhibition.

198 Notably, the classical esterase activity of AChE is dispensable for this activity.

199 choline to thiocholine where the activity of AChE is inhibited by the presence of organophosphate pes

200 led the probing of the enzymatic activity of AChE through the hemin/G-quadruplex-catalyzed aerobic ox

201 Subsequent crystallographic analyses of AChE complexes with the TZ2PA6 regioisomers demonstrated

202 Analysis of AChE expression indicated that, in contrast to evidence

203 were observed of the proline-rich anchor of AChE, PRiMA, no changes were seen in mRNA levels of the

204 iculum network where they induce assembly of AChE tetramers.

205 ARs in terms of their inhibition capacity of AChE.

206 the large scale intracellular degradation of AChE previously observed and indicate that simple peptid

207 ing high promise for label-free detection of AChE and its inhibitors.

208 dable paper-based biosensor for detection of AChE inhibitors.

209 dent samples, the adult-like distribution of AChE in the core area of auditory cortex, dense bands in

210 ation, cytoarchitecture, and distribution of AChE in the hippocampal formation of the Atlantic white-

211 number of differences in the distribution of AChE staining in areas comparable to those of terrestria

212 ough silica sol-gel (SiSG) immobilisation of AChE on the carbon paste electrode (CPE) and used as wor

213 The pharmacological inactivation of AChE by neostigmine caused the appearance of an ultra-sl

214 -range spillover produced by inactivation of AChE.

215 function than the simultaneous inhibition of AChE and BChE because the concomitant inhibition of BChE

216 Compound 44 showed mixed inhibition of AChE in the enzyme kinetic studies.

217 In myasthenic rats, selective inhibition of AChE is more effective in rescuing muscle function than

218 nds exhibited moderate to high inhibition of AChE-induced Abeta1-42 aggregation and noticeable in vit

219 as identified as the first dual inhibitor of AChE and microRNA-15b biogenesis.

220 of MG-6267 to single-targeted inhibitors of AChE and microRNA-15b in protecting SH-SY5Y neuroblastom

221 utilized to develop reversible inhibitors of AChE into reactivators of nerve agent-inhibited AChE.

222 l changes due to shRNA-mediated knockdown of AChE were rescued by coinfusion of an shRNA-resistant AC

223 nd SH-SY5Y substantially decreased levels of AChE mRNA, protein, and catalytic activity.

224 In silico docking using a model of AChE permitted rationalization of the observed SAR.

225 levels as low as 100 pM (22,000 molecules of AChE) can be detected.

226 ors and the peripheral anionic site (PAS) of AChE.

227 In addition, the AWSD had a rich pattern of AChE staining that distinctly varied between regions and

228 ered by a conformationally rigid portrait of AChE extracted exclusively from 100K X-ray crystallograp

229 Y (APP695) cells, showing that regulation of AChE by APP does not require the generation of AICD or a

230 t the observed transcriptional repression of AChE is mediated by the E1 region of APP, specifically i

231 sion from 18 to 24 months led to reversal of AChE sprouting, resolution of Gallyas-positive and Alz50

232 ropidium from the peripheral anionic site of AChE, preventing the beta-amyloid aggregation promoted b

233 e site as well as peripheral anionic site of AChE.

234 -soaking procedures and solved structures of AChE complexes with the TZ2PA5 regioisomers and their TZ

235 ffinity about five times higher than that of AChE.

236 The proposed biosensor based on AChE immobilized in sol-gel matrix was used for the dete

237 echanism of intrinsic reactivation of the OP-AChE conjugate and penetration of the blood-brain barrie

238 luding oxime reactivators that attack the OP-AChE conjugate to free the active enzyme, are inefficien

239 enhanced intrinsic reactivity against the OP-AChE target combined with favorable pharmacokinetic prop

240 d UV-vis methods on the MWCNT-(PEI/DNA)2/OPH/AChE biosensor, showing great potential in large screeni

241 Using an EDA approach, other AChE inhibiting candidates were identified in the neutra

242 elective inhibitory action against BChE over AChE and CaE.

243 The GC/MWCNT/PANI/AChE biosensor exhibited detection limits of 1.4 and 0.9

244 Irradiated TCPF and EC are more potent AChE inhibitors than irradiated EW.

245 rid, and pirimicarb, and was the most potent AChE inhibitor.

246 mote AChE tetramerization in cells producing AChE.

247 omain of collagen Q is sufficient to promote AChE tetramerization in cells producing AChE.

248 on method to enrich red blood cell AChE (RBC AChE) as a biomarker of exposure.

249 esent work was to provide an alternative RBC AChE enrichment strategy, by binding RBC AChE to Hupresi

250 RBC AChE enrichment strategy, by binding RBC AChE to Hupresin affinity gel.

251 The same protocol was used for 20 mL of RBC AChE inhibited with a soman model compound.

252 The red, but not viscous, RBC AChE solution was loaded on a Hupresin affinity column.

253 nds showed a promising ability to reactivate AChE inhibited by various types of CWA in vitro.

254 owed HFD consumption to significantly reduce AChE activity in the frontal cortex, hypothalamus and mi

255 in vitro potency with significantly reduced AChE activity.

256 say method was validated using the reference AChE inhibitors tacrine and galanthamine.

257 rescued by coinfusion of an shRNA-resistant AChE transgene into the hippocampus and reversed by syst

258 re washed off with 3 M NaCl, while retaining AChE bound to Hupresin.

259 ened miR-608 interaction with the rs17228616 AChE allele having a single-nucleotide polymorphism (SNP

260 Mean (+/- SD) AChE activity was 3.14 +/- 0.49 U/mL.

261 ygote for the minor rs17228616 allele showed AChE elevation and CDC42/IL6 decreases compared with maj

262 ion to its role in nervous system signaling, AChE can also modulate non-neuronal cell properties, alt

263 type-II cells presented less ChAT, but some AChE on their surfaces.

264 port our hypothesis that the insect-specific AChE cysteine is a unique and unexplored target to devel

265 interact as mixtures to produce synergistic AChE inhibition at concentrations near or above the uppe

266 tains an amphiphilic C-terminal domain (T40, AChE(575-614)), with AChE(586-599) homologous to Abeta a

267 nts expressing dsRNA homologous to B. tabaci AChE and EcR were constructed by fusing sequences derive

268 igmine or virally delivered shRNAs targeting AChE into the hippocampus.

269 ight be attributed to a mechanism other than AChE inhibition.

270 ense morpholino or CRISPR-Cas9) confirm that AChE is specifically required in the gut endoderm tissue

271 in this capacity in vivo Here, we show that AChE plays an essential non-classical role in vertebrate

272 We have previously shown that AChE in skeletal muscle is regulated in part post-transl

273 The AChE activities were decreased to 32% to 85% of control

274 The AChE-catalyzed hydrolysis of acetylthiocholine to the th

275 To test this hypothesis, we administered the AChE inhibitor physostigmine to mice and demonstrated an

276 enzyme acetylcholinesterase (AChE), and the AChE-ICERs produced were used in a liquid chromatograph-

277 Noteworthy is that the AChE LC sensor shows a very high sensitivity for the det

278 ility and arrhenius plots suggested that the AChE was made up of two forms that differed in their the

279 When the sensor with the AChE enzyme is put in contact with acetylthiocholine (AT

280 und inhibits this signal by binding with the AChE enzyme.

281 ion of the antidotes' nucleophile within the AChE active-center gorge.

282 nsional retention alignment as well as their AChE inhibition activity.

283 its from HTS were further screened for their AChE inhibitory activity, the most widely investigated t

284 ity (>0.9) separation was achieved and three AChE inhibitors (tiapride, amisulpride, and lamotrigine)

285 different order of effectiveness compared to AChE inhibition.

286 Exposure of Xenopus embryos to AChE-inhibiting chemicals results in severe defects in i

287 d EPSCs are reliable and highly sensitive to AChE activity.

288 Electrophoresis showed the presence of two AChE bands that did not change in position or intensity

289 Typical AChE-based interfering species did not affect the PHA pe

290 In contrast, tacrine and donepezil, typical AChE inhibitors, could not prevent synaptic impairments

291 he optical appearance was then observed when AChE was transferred onto the Myr-decorated LC interface

292 s, although it remains controversial whether AChE functions in this capacity in vivo Here, we show th

293 C-terminal domain (T40, AChE(575-614)), with AChE(586-599) homologous to Abeta and forming amyloid fi

294 is of one of those compounds in complex with AChE allowed rationalizing the outstanding activity data

295 Crystal structures of their complexes with AChE and BChE revealed the molecular basis for their hig

296 n as well as their ability to interfere with AChE-induced aggregation of beta-amyloid (Abeta), and Ab

297 ic blood pressure (DBP), and heart rate with AChE activity, living with flower workers, duration of c

298 Under optimum conditions, the Pt/ZnO/AChE/Chitosan bio-electrode detected carbosulfan ranging

299 The developed Pt/ZnO/AChE/Chitosan bio-electrode showed good recovery (99.06-

300 The Pt/ZnO/AChE/Chitosan bio-electrode was employed for the electro